SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-00-003844
Filing Date
2000-04-19
Accepted
2000-04-19 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D SC 13D/A 9954
2 ASSIGNMENT EX-99.1 44478
3 AMENDMENT #1 TO SHAREHOLDER AGREEMENT EX-99.2 6168
4 PRESS RELEASE EX-99.3 3191
  Complete submission text file 0000950123-00-003844.txt   65914
Mailing Address
Business Address 10150 OLD COLUMBIA ROAD COLUMBIA MD 21046 4103097100
NORTH AMERICAN VACCINE INC (Subject) CIK: 0000856573 (see all company filings)

IRS No.: 980121241 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49421 | Film No.: 604884
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Filed by) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances